Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Deb 2% CHG Foaming Skin Cleanser Chlorhexidine gluconate 20mg/g Topical solution SC Johnson Professional NZ Limited SC Johnson Professional CA Inc, Brantford, Canada
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Herzuma Trastuzumab 150mg Powder for infusion concentrate CARSL Consulting Celltrion Inc., Incheon, South Korea
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Herzuma Trastuzumab 440mg Powder for infusion concentrate CARSL Consulting Celltrion Inc., Incheon, South Korea
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Isentress HD Raltegravir potassium 651.6mg equivalent to raltegravir 600mg Film coated tablet Merck Sharp & Dohme (New Zealand) Limited MSD International GmbH (Singapore Branch), Singapore, Singapore
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Rivastigmine Patch 5 Rivastigmine 9mg Transdermal patch Generic Partners (NZ) Limited SK Chemicals Co. Limited, Cheongju-si, South Korea
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Rivastigmine Patch 10 Rivastigmine 18mg Transdermal patch Generic Partners (NZ) Limited SK Chemicals Co. Limited, Cheongju-si, South Korea
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Rivastigmine Patch 15 Rivastigmine 27mg Transdermal patch Generic Partners (NZ) Limited SK Chemicals Co. Limited, Cheongju-si, South Korea
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Valganciclovir Valganciclovir hydrochloride 496.286mg equivalent to valganciclovir 450mg Film coated tablet Max Health Limited Oman Pharmaceutical Products Company LLC, Salalah, Oman
|
Dated this 14th day of June 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on the 11th day of September 2013).